2017 was a good year for Johnson & Johnson (JNJ) , as shares rallied some 21%. However, 2018 may not carry the same fortunes.

It may only be January 2, but the analysts at JPMorgan aren't wasting any time. Analyst Michael Weinstein downgraded J&J stock to neutral from outperform. However, he's maintaining his $150 price target for the stock, which implies about 7% upside from current levels.

Given the lower rating yet higher price target, it's not surprising to see the stock's lacking reaction to JPMorgan's move. Although Weinstein remains "fundamentally bullish" on J&J, he makes the case that at 17.9 times 2018 earnings estimates, there are simply more attractive stocks to own.

Specifically, he likes Baxter International (BAX) and Abbott Laboratories (ABT) . He upgraded both to overweight as a result.

Ironically, Weinstein wasn't the only bull for these stocks Tuesday. Bank of America/Merrill Lynch analyst Bob Hopkins upgraded Baxter to buy from neutral, bumping his price target to $73 from $64. The target implies about 14% upside from current levels.

As for Abbott, Morgan Stanley's David Lewis upgraded the stock to overweight from equal weight and raised his price target to $67 from $60. Lewis' price target implies about 17% upside from current levels. New product launches should drive organic growth for Abbott, as revenue and profit growth accelerate. This "premium growth will likely be rewarded with a premium multiple," Lewis contends, driving Abbott stock higher.

So the verdict isn't necessarily that J&J is a bad stock to own. Instead, it's that J&J stock has less upside than the 14% and 17% some analysts see in Baxter and Abbott, respectively.

Abbott Laboratories is a holding in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio. Want to be alerted before Cramer buys or sells ABT? Learn more now.

More of What's Trending on TheStreet:

This article is commentary by an independent contributor. At the time of publication, the author had no positions in the stocks mentioned.

More from Stocks

Quick Read: 3 Things for Investors to Know Before Wednesday's Trading Session

Quick Read: 3 Things for Investors to Know Before Wednesday's Trading Session

Replay: Jim Cramer on the Markets, Oil, General Electric, Zillow and Micron

Replay: Jim Cramer on the Markets, Oil, General Electric, Zillow and Micron

Pegasystems Founder Explains Why He Has One of the Hottest Tech Stocks Around

Pegasystems Founder Explains Why He Has One of the Hottest Tech Stocks Around

Micron Shares Soar; Chipmaker Is 'Managing for Profitability' Now, Says Analyst

Micron Shares Soar; Chipmaker Is 'Managing for Profitability' Now, Says Analyst

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline